🔗 Share this article

An underground economy for unapproved weight-loss drugs is being driven by TikTok fitness influencers and sellers on communication apps, based on recent findings.

Investigational Drug Gaining Traction Via Social Media

Retatrutide, which is still in clinical trials, is being promoted by social media influencers for its alleged weight-reducing properties. Followers are encouraged to message these accounts directly for supplier links, while also receiving promotional offers.

Active Commerce on Social Networks

Separately, a robust trade exists on messaging services, where groups with thousands of members share “before and after” images, injection guides and claims of next-day British shipping. Vendors promote the drug there before directing customers to WhatsApp for purchases.

Understanding Retatrutide

This medication is an experimental injection created by US drugmaker Eli Lilly. The drug targets three intestinal hormones – glucagon-like peptide-1, glucose-dependent insulinotropic polypeptide and pancreatic hormone. Preliminary studies indicate it could help individuals lose up to a quarter of their body weight. Nicknamed the “triple G”, the substance is being hailed online as the next Ozempic.

Healthcare Professionals Express Worries

However, doctors and pharmacists have cautions that the distribution of what is still an unlicensed drug in the UK is worrisome and could result in individuals administering substances of uncertain source.

Several experts stated the demand for the experimental drug could be linked to the increasing cost of licensed weight loss treatments such as Mounjaro.

Regulatory Position and Enforcement

Selling the unapproved drug on TikTok or Telegram is illegal in the United Kingdom, as it is an unlicensed drug that must not be marketed or distributed for personal consumption under the British medical regulations.

Several content creators try to circumvent the regulations by calling to the drug as a “research chemical” or describing it as “not for human consumption”. Retatrutide is not a controlled substance, but advertising and distribution can still breach medicines, marketing, and customer laws, risking penalties, prosecution or imprisonment.

Platform Reaction and Content Elimination

According to the social media company, the service has taken down violative content and banned related hashtags and query recommendations. The company said it was dedicated to keeping the service safe and investing in enhancing compliance measures.

Digital Trading Activities

Investigations also found communities with up to nine thousand members selling retatrutide using the platform's integrated search feature, which functions like a public directory. Typing “retatrutide” instantly displays channels with thousands of users, filled with photos of slimming results, glowing reviews and detailed guides for mixing or administering at residence.

Within minutes of joining one group, a seller posted WhatsApp details, where the majority of transactions take place. The vendor sent an guidebook and promised shipping within 48 hours. When asked whether the substance was genuine, one seller responded: “You can’t be sure.” Another provided a photo of a supposed testing documentation. Not one inquired about weight, health issues or past usage.

Item Details and Costs

Inside these communities, messages display black plastic packages with Royal Mail stickers, claiming to contain new batches. One communication stated: “It took eight of us to load them this morning.”

Customers can select between powder vials, mixed at home with sterile water, or ready-to-use pens typically priced at £160 for 20mg. When asked how long a pen should last, sellers give contradictory responses varying between a several days to “depends on your body”.

Platform Moderation and Safety Actions

A representative for the messaging service stated it actively moderated dangerous content on its service including material that encouraged the “misuse of controlled medications”. The company added that it removed “millions of pieces of harmful content each day”.

Healthcare Professional Warnings

“People are injecting substances they can’t verify. Although the science behind retatrutide is sound, these digital products may not include what they advertise,” said Jason Murphy, the director of pharmacy at Chemist4U.

Dr Crystal Wyllie of an online medical service connected the surge in interest to current cost increases for approved weight-loss medications such as Mounjaro. “With prices increasing, individuals are using social media. But fake treatments are extremely dangerous. You can’t be certain what’s contained or whether the conditions they were made in was clean,” she said.

Her team has previously seen individuals injured by self-injection from unconfirmed sources. “We understand the frustration, but purchasing from messaging apps or WhatsApp is taking chances with your health,” said Wyllie. “These materials could be impure or incorrectly dosed.”

Producer Position

A representative from Eli Lilly said the substance was in phase 3 research studies and had not been reviewed or authorized by any government authority anywhere in the world. “Consequently at this point no one can sell [it] for human use,” they said, adding that any product “falsely representing itself as a company investigational substance not yet approved … may expose patients to potentially serious health risks”.